retatrutide side effects trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide Side Effects: What Clinical

The debate surrounding GLP-1 medicines presents a remarkably similar challenge, but in a less visible context

Setting realistic expectations based on mechanism and magnitude prevents disappointment and wasted money

The Association of Anaesthetists , in collaboration with the Royal College of Anaesthetists (RCoA), Centre for Perioperative Care (CPOC), and the Joint British Diabetes Societies (JBDS), has published recommendations addressing the management of patients taking these medications before surgery

It requires daily consistency and a strict morning routine that not every schedule can accommodate

It often arrives unannounced, making it challenging to pinpoint when it begins

Interpreting findings from such designs can be difficult, as they are more susceptible to bias and confounding, and feature small sample sizes, limiting the ability to establish causality